Drug Shortage Report for MAR-RANITIDINE
Report ID | 94584 |
Drug Identification Number | 02443716 |
Brand name | MAR-RANITIDINE |
Common or Proper name | RANITIDINE |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 Tablet |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-09-16 |
Actual start date | 2019-09-16 |
Estimated end date | 2020-01-10 |
Actual end date | 2020-01-10 |
Shortage status | Resolved |
Updated date | 2020-01-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-09-24 | English | Compare |
v2 | 2019-09-24 | French | Compare |
v3 | 2020-01-14 | English | Compare |
v4 | 2020-01-14 | French | Compare |
Showing 1 to 4 of 4